William Blair Investment Management
TEVA icon

William Blair Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

William Blair Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223M Buy
6,593,221
+5,167,554
+362% +$172M 0.67% 30
2026
Q1 		$42.9M Buy
+1,425,667
New +$45.9M 0.14% 149
2025
Q1 		– Sell
-4,241,547
Closed -$93.5M – 456
2024
Q4 		$93.5M Sell
4,241,547
-105,451
-2% -$1.92M 0.23% 118
2024
Q3 		$78.3M Buy
+4,346,998
New +$76.1M 0.19% 119
2016
Q3 		– Sell
-3,357,060
Closed -$169M – 467
2016
Q2 		$169M Sell
3,357,060
-1,770,847
-35% -$94.3M 0.67% 50
2016
Q1 		$274M Sell
5,127,907
-1,123,083
-18% -$65.9M 1.09% 12
2015
Q4 		$410M Buy
6,250,990
+729,749
+13% +$45.1M 1.66% 3
2015
Q3 		$312M Buy
+5,521,241
New +$358M 0.64% 10

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

William Blair Investment Management's TEVA Position: Q2 2026 in Review

William Blair Investment Management increased its Teva Pharmaceuticals (TEVA) stake by 362% in Q2 2026, buying an estimated $172M and bringing the position to 6,593,221 shares worth $223M. The position accounts for 0.67% of the portfolio, ranked #30.

William Blair Investment Management first reported a position in TEVA in Q3 2015 and has held it in 8 quarters since. The position peaked at $410M in Q4 2015. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • William Blair Investment Management held 6,593,221 shares of Teva Pharmaceuticals worth $223M as of Q2 2026.
  • William Blair Investment Management bought 5,167,554 Teva Pharmaceuticals shares in Q2 2026, an estimated $172M.
  • Teva Pharmaceuticals made up 0.67% of William Blair Investment Management's portfolio in Q2 2026, its #30 holding.
  • William Blair Investment Management first reported a position in Teva Pharmaceuticals in Q3 2015 and has held it in 8 quarters since.
  • William Blair Investment Management's Teva Pharmaceuticals position peaked at $410M in Q4 2015.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on William Blair Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.